A Open Label Study of the Effect of First-line Therapy With Xeloda in Combination With Oxaliplatin on Overall Response Rate in Patients With Locally Advanced and/or Metastatic Gastric Cancer
Phase of Trial: Phase II
Latest Information Update: 08 Jul 2015
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- Sponsors Roche
- 18 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Feb 2009 Planned end date changed from 1 Mar 2011 to 1 Nov 2010, as reported by ClinicalTrials.gov.
- 25 Feb 2009 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.